Business
Acquisition of Integrity Orthopaedics
Smith+Nephew has acquired Integrity Orthopaedics for an initial US$225 million cash payment plus up to US$225 million in performance-based payments over five years, aiming to strengthen its sports medicine portfolio with the Tendon Seam™ rotator cuff repair technology. This acquisition is expected to be accretive to Group trading profit margin by 2028 and is financed from existing cash facilities, keeping the Group below its leverage target of 2x EBITDA. The transaction, which is expected to close by the end of January 2026, enhances Smith+Nephew's offerings in the substantial and growing rotator cuff repair market, estimated at US$875 million annually. Disclaimer*
About this update from Smith & Nephew Plc
[{"type":"text","content":"\n\nSmith+Nephew strengthens shoulder repair portfolio with acquisition of sports medicine business Integrity Orthopaedics and its novel Tendon Seam™ rotator cuff repair technology\n12 January 2026\n \nSmith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the acquisition of Integrity Orthopaedics, a US‑based early‑stage commercial developer of Tendon Seam™, an innovative rotator cuff repair (RCR) system designed to significantly reduce re‑tear rates and improve patient outcomes.\nThe acquisition represents a meaningful step in delivering Smith+Nephew's RISE strategy to accelerate growth through strategic investment and portfolio leadership, and will be an important building block in our ambition to become the global leader in Sports Medicine.\nRCR is a substantial and growing treatment area, with approximately 500,000 procedures performed annually in the US and an estimated market value of $875 million1. Yet traditional surgical techniques have historically suffered from high structural failure rates, averaging 20-40%2.\nTendon Seam™ directly addresses this unmet clinical need. Its patented micro‑anchors, continuous suture, individually locked stitches, and integrated implantation instrument are designed to deliver stronger repairs, accelerated patient recovery, lower re‑tear rates, and a simplified surgical technique. Early clinical experience indicates low re‑tear rates, reduced sling times and shorter procedures compared with standard methods3. The system received 510(k) clearance in 2023 and is indicated for reattachment of soft tissue to bone, including tendons, ligaments, and joint capsules.\nIntegrity Orthopaedics was founded in 2020 and is headquartered in Maple Plain, MN, US. Its founders include Tom Westling, co-founder of Rotation Medical, the developer of the REGENETEN◊ Bioinductive Implant, which was acquired by Smith+Nephew in 2017.\nScott Schaffner, President Sports Medicine, Smith+Nephew, said:\n\"Smith+Nephew now has an unrivalled portfolio for shoulder, including a powerful next‑generation rotator cuff repair platform to complement market-leading biological augmentation, the newest shoulder arthroplasty system, and proven solutions across shoulder instability. We welcome the Integrity team, including those involved with our prior successful acquisition of Rotation Medica...